# Soufflé Therapeutics **Source:** https://www.startuphub.ai/startups/souffl-therapeutics **Profile type:** Startup > A leading RNA therapies company advancing next-generation cell-selective siRNA-based medicines for various diseases. ## About Soufflé Therapeutics is a biotechnology company focused on developing potent, precise, and safe RNA medicines. They utilize proprietary technologies to identify cell-specific receptors, optimize ligands, and engineer siRNA to deliver therapies that precisely target and enter disease-causing cells. Their initial programs address muscle dystrophies, heart failure, and metabolic disorders. ## Key facts - **Slug:** souffl-therapeutics - **Website:** https://souffletx.com - **Location:** Watertown, United States - **Founded:** 2021-01-01 - **Operating status:** Active - **Total funding:** $135M - **Sectors / tags:** Biotech, MedTech, Genomics, Drug Discovery, RNA Therapeutics - **Social:** - LinkedIn: https://www.linkedin.com/company/vc-backed-biotech-newco ## StartupHub.ai scores - **Ahrefs DR:** 25/100 - **Effective DR:** 100/100 - **Agent Readiness:** D (41/100) - **Site Speed:** 67/100 - **Data Trust:** 73/100 ## Funding rounds | Date | Round | Amount | Lead investors | | --- | --- | --- | --- | | 12 Oct 2026 | [Series B](https://www.startuphub.ai/investment_rounds/souffl-therapeutics-series-b-2026) | $135M | - | ## Tech stack Detected on souffletx.com, last scanned 2026-10-17. - **Analytics:** Google Analytics 4 - **Hosting:** AWS - **Email provider:** Microsoft 365 ## JSON-LD Structured data aligned with this page's `